Cell surface HER2/neu expression remained high on tumor cells after trastuzumab, α-TEA or α-TEA+trastuzumab treatment (Figure 5) compared to tumor cells from isotype-treated mice and HER2/neu expression levels of tumor cells at the time of tumor implantation (pre-injection). The gene discussed is ERBB2; the disease is neoplasm.